Research Capital analyst Andre Uddin keeps Speculative Buy rating on Sernova BiotherapeuticsUddin said Sernova reported its Q2 results, though financials remain secondary as the company is still in the clinical stage.
Research Capital analyst Andre Uddin keeps Speculative Buy rating on Sernova BiotherapeuticsUddin said Sernova reported its Q2 results, though financials remain secondary as the company is still in the clinical stage.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
trades and holding each position for 1 Month would result in 25.00% of your transactions generating a profit, with an average return of -3.69% per trade.
trades and holding each position for 3 Months would result in 37.50% of your transactions generating a profit, with an average return of -7.52% per trade.
Copying Joseph Pantginis's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -30.31% per trade.
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -35.39% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
SVA Analyst Recommendation Trends
Rating
Mar 25
Apr 25
May 25
Jun 25
Jul 25
Strong Buy
1
2
2
4
4
Buy
0
0
0
0
0
Hold
1
1
0
0
0
Sell
5
6
6
3
0
Strong Sell
0
0
0
0
0
total
7
9
8
7
4
In the current month, SVA has received 4Buy Ratings, 0Hold Ratings, and 0Sell Ratings. SVA average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.
SVA Stock Forecast FAQ
What is TSE:SVA’s average 12-month price target, according to analysts?
Currently, no data Available
What is TSE:SVA’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for TSE:SVA, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is TSE:SVA a Buy, Sell or Hold?
Currently, no data Available
What is Sernova’s price target?
Currently, no data Available
What do analysts say about Sernova?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of TSE:SVA?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.